跳至主要内容
临床试验/NCT03016364
NCT03016364Unknown1 期

Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年1月最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
200
试验地点
1
主要终点
Numerical Pain Rating Scale

研究概览

简要总结

The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a histologically confirmed diagnosis of Cancer or Sarcoma
  • advanced patients with severe cancer pain(score >3)
  • having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets

排除标准

  • allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids

研究组 & 干预措施

APP in dosage adjustment

Experimental

Through the guidance of APP software, clinical doctors try to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain.

干预措施: APP software (Device)

结局指标

主要结局

Numerical Pain Rating Scale

时间窗: upto 8 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peng Liu

Attending Physician

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Application Software in Dosage Adjustment for... | 临床试验